/West%20Pharmaceutical%20Services%2C%20Inc_%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
With a market cap of $17.6 billion, West Pharmaceutical Services, Inc. (WST) is a global leader in innovative containment and delivery systems for injectable drugs and healthcare products. Operating through its Proprietary Products and Contract-Manufactured Products segments, the company serves pharmaceutical, biologic, and medical device customers worldwide.
Shares of the Exton, Pennsylvania-based company have underperformed the broader market over the past 52 weeks. WST stock has decreased 18.5% over this time frame, while the broader S&P 500 Index ($SPX) has gained nearly 15%. Moreover, shares of the company have declined 24.7% on a YTD basis, compared to SPX's nearly 10% rise.
